Abstract:The mechanism of SENPs involved in human oxidative stress‐related diseases. Oxidative stress is employed to depict a series of responses detrimental to normal cellular functions resulting from an imbalance between intracellular oxidants, mainly reactive oxygen species and antioxidant defenses. Oxidative stress often contributes to the development of various diseases, including cancer, cardiovascular diseases, and neurodegenerative diseases. In this process, the relationship between small ubiquitin‐like modifier (SUMO) and oxidative stress has garnered significant attention, with its posttranslational modification (PTM) frequently serving as a marker of oxidative stress status. Sentrin/SUMO‐specific proteases (SENPs), affected by alternative splicing, PTMs such as phosphorylation and ubiquitination, and various protein interactions, are crucial molecules in the SUMO process. The human SENP family has six members (SENP1–3, SENP5–7), which are classified into two categories based on sequence similarity, substrate specificity, and subcellular location. They have two core functions in the human body: first, by cleaving the precursor SUMO and exposing the C‐terminal glycine, they initiate the SUMO process; second, they can specifically recognize and dissociate SUMO proteins bound to substrates, a process known as deSUMOylation. However, the connection between deSUMOylation and oxidative stress remains a relatively unexplored area despite their strong association with oxidative diseases such as cancer and cardiovascular disease. This article aims to illustrate the significant contribution of SENPs to the oxidative stress pathway through deSUMOylation by reviewing their structure and classification, their roles in oxidative stress, and the changes in their expression and activity in several typical oxidative stress‐related diseases.

Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay

Quantitative and subcellular localization analysis of the nuclear isoform dUTP pyrophosphatase in alkylating agent-induced cell responses

Differential Nuclear Proteomes in Response to N-Methyl-N '-Nitro-n-nitrosoguanidine Exposure

SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation.

Caspase-3 Suppresses Diethylnitrosamine-Induced Hepatocyte Death, Compensatory Proliferation and Hepatocarcinogenesis Through Inhibiting P38 Activation

The Critical Roles of the SUMO-Specific Protease SENP3 in Human Diseases and Clinical Implications

SENP3 Regulates the Global Protein Turnover and the Sp1 Level Via Antagonizing SUMO2/ 3-Targeted Ubiquitination and Degradation

Proteomic Profiling of Expression of Proteasomal Subunits from Livers of Mice Treated with Diethylnitrosamine

Two‐dimensional Differential Gel Electrophoresis/analysis of Diethylnitrosamine Induced Rat Hepatocellular Carcinoma

Proteomic analysis of DEN and CCl4-induced hepatocellular carcinoma mouse model

The Responses of SENP3 to Different Extents of Oxidative Stress

Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation

SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease

Research progress of SENP inhibitors and SENP inhibitor bioassay methods

Nuclear Proteome Analysis of Benzo(a)pyrene-Treated HeLa Cells.

Uncovering SOD3 and GPX4 as new targets of Benzo[]pyrene-induced hepatotoxicity through Metabolomics and Chemical Proteomics

SUMO‐specific proteases: SENPs in oxidative stress‐related signaling and diseases

Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90.

SENP3-mediated De-conjugation of SUMO2/3 from Promyelocytic Leukemia Is Correlated with Accelerated Cell Proliferation under Mild Oxidative Stress

Proteomics revealed composition- and size-related regulators for hepatic impairments induced by silica nanoparticles

Identification of SENP1 Inhibitors Through in Silico Screening and Rational Drug Design.